Aluma Endovascular Systems

Company Overview

Snapshot

Founded in August 2025 by Ori Kanner, Aluma Endovascular Systems operates with 1–10 employees. The company has secured funding across two rounds from Peregrine Ventures, with its last funding round occurring in October 2025.

Business overview

Aluma Endovascular Systems develops advanced laser energy delivery systems that integrate proprietary fiber technology into catheters. This technology is designed to deliver highly localized, high-energy laser pulses to targeted areas, aiming to overcome the power limitations of existing solutions. The company's innovation initially focuses on addressing unmet medical needs for patients with chronic diseases in small arteries, a condition with limited treatment options. Operating within the Health Tech & Life Sciences sector, specifically Medical Devices and Medical Treatment & Therapeutics, Aluma Endovascular Systems serves the medical industry by blending technological and clinical expertise through collaborations with Elbit Systems and Shaare Zedek Scientific Ltd.

Company Intelligence Q&A

When was Aluma Endovascular Systems founded?

Aluma Endovascular Systems was founded in August 2025.

Who are the founders of Aluma Endovascular Systems?

Ori Kanner is a Co-Founder and CEO of Aluma Endovascular Systems.

What is Aluma Endovascular Systems' primary focus?

Aluma Endovascular Systems focuses on developing advanced laser energy delivery systems with proprietary fiber technology integrated into catheters, targeting chronic diseases in small arteries.

Which investor participated in Aluma Endovascular Systems' funding rounds?

Peregrine Ventures participated in Aluma Endovascular Systems' funding rounds in September and October 2025.

What is the product stage of Aluma Endovascular Systems?

Aluma Endovascular Systems is currently in the R&D product stage, as of October 2025, following its seed funding rounds.